RUNX1 and glioblastoma: Collectively, these results demonstrate that USP10 can significantly induce the activation of RUNX1, and the USP10/RUNX1 molecular axis significantly affects clinical outcomes of GBM by promoting PMT in GBM (summarized in Fig. 7F).